USD 1.14
(-7.67%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -14.65 Million USD | 14.9% |
2022 | -17.21 Million USD | -71.04% |
2021 | -10.06 Million USD | -110.71% |
2020 | -4.77 Million ILS | -0.35% |
2019 | -4.76 Million ILS | -34.7% |
2018 | -3.53 Million ILS | -22.89% |
2017 | -2.87 Million ILS | 12.06% |
2016 | -3.27 Million ILS | 12.84% |
2015 | -3.75 Million ILS | 20.41% |
2014 | -4.71 Million ILS | -3.05% |
2013 | -4.57 Million ILS | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -3.57 Million USD | -13.45% |
2024 Q2 | -3.03 Million USD | 13.86% |
2023 Q3 | -4 Million USD | -2.85% |
2023 FY | -14.65 Million USD | 14.9% |
2023 Q1 | -3.57 Million USD | 9.89% |
2023 Q2 | -3.88 Million USD | -8.66% |
2023 Q4 | -3.15 Million USD | 21.18% |
2022 Q2 | -4.76 Million USD | -6.53% |
2022 FY | -17.21 Million USD | -71.04% |
2022 Q4 | -3.97 Million USD | 1.07% |
2022 Q1 | -4.46 Million USD | -41.42% |
2022 Q3 | -4.01 Million USD | 15.67% |
2021 Q4 | -3.16 Million USD | -9.42% |
2021 Q2 | -2.47 Million USD | -80.6% |
2021 Q1 | -1.37 Million USD | -75.1% |
2021 FY | -10.06 Million USD | -110.71% |
2021 Q3 | -2.88 Million USD | -16.64% |
2020 FY | -4.77 Million ILS | -0.35% |
2020 Q4 | -783 Thousand USD | 41.96% |
2020 Q2 | -799 Thousand USD | 0.0% |
2020 Q1 | -799 Thousand USD | 28.51% |
2020 Q3 | -1.34 Million USD | -68.84% |
2019 Q3 | -1.11 Million USD | 10.07% |
2019 Q4 | -1.11 Million USD | -0.66% |
2019 FY | -4.76 Million ILS | -34.7% |
2019 Q2 | -1.23 Million USD | -1.79% |
2019 Q1 | -1.21 Million USD | -20.25% |
2018 Q1 | -916.77 Thousand USD | -28.01% |
2018 FY | -3.53 Million ILS | -22.89% |
2018 Q4 | -1 Million USD | -16.99% |
2018 Q3 | -862.15 Thousand USD | 1.47% |
2018 Q2 | -874.99 Thousand USD | 4.56% |
2017 Q3 | -762.02 Thousand USD | -10.55% |
2017 FY | -2.87 Million ILS | 12.06% |
2017 Q4 | -716.17 Thousand USD | 6.02% |
2017 Q1 | -663.87 Thousand USD | 13.12% |
2017 Q2 | -689.3 Thousand USD | -3.83% |
2016 Q4 | -764.16 Thousand USD | -30.68% |
2016 Q1 | -1.14 Million USD | -55.27% |
2016 Q2 | -820.02 Thousand USD | 28.07% |
2016 Q3 | -584.73 Thousand USD | 28.69% |
2016 FY | -3.27 Million ILS | 12.84% |
2015 Q3 | -949.83 Thousand USD | 6.66% |
2015 Q4 | -734.24 Thousand USD | 22.7% |
2015 Q2 | -1.01 Million USD | 4.15% |
2015 Q1 | -1.06 Million USD | -7.67% |
2015 FY | -3.75 Million ILS | 20.41% |
2014 Q3 | -1.25 Million USD | -0.57% |
2014 FY | -4.71 Million ILS | -3.05% |
2014 Q1 | -1.61 Million USD | -43.48% |
2014 Q2 | -1.24 Million USD | 22.85% |
2014 Q4 | -986.06 Thousand USD | 21.25% |
2013 Q4 | -1.12 Million USD | -2.54% |
2013 Q1 | -1.04 Million USD | 13.21% |
2013 FY | -4.57 Million ILS | 0.0% |
2013 Q2 | -1.19 Million USD | -14.97% |
2013 Q3 | -1.09 Million USD | 8.53% |
2012 Q4 | -1.2 Million USD | -4.31% |
2012 Q3 | -1.15 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Accelerate Diagnostics, Inc. | -61.61 Million USD | 76.221% |
BrainsWay Ltd. | -4.19 Million USD | -249.107% |
Cerus Corporation | -37.48 Million USD | 60.917% |
Envoy Medical, Inc. | -29.9 Million USD | 51.01% |
electroCore, Inc. | -18.83 Million USD | 22.205% |
Helius Medical Technologies, Inc. | -8.85 Million USD | -65.559% |
Inogen, Inc. | -102.44 Million USD | 85.698% |
OrthoPediatrics Corp. | -20.97 Million USD | 30.142% |
Lucid Diagnostics Inc. | -52.66 Million USD | 72.179% |
Monogram Orthopaedics, Inc. | -13.74 Million USD | -6.597% |
MaxCyte, Inc. | -37.92 Million USD | 61.364% |
NeuroOne Medical Technologies Corporation | -11.85 Million USD | -23.547% |
Nexalin Technology, Inc. | -4.64 Million USD | -215.184% |
Orthofix Medical Inc. | -151.39 Million USD | 90.322% |
PAVmed Inc | -64.17 Million USD | 77.169% |
Rapid Micro Biosystems, Inc. | -52.46 Million USD | 72.074% |
RxSight, Inc. | -48.6 Million USD | 69.857% |
Sight Sciences, Inc. | -55.54 Million USD | 73.622% |
SI-BONE, Inc. | -43.33 Million USD | 66.19% |
TELA Bio, Inc. | -46.66 Million USD | 68.601% |
Treace Medical Concepts, Inc. | -49.52 Million USD | 70.416% |
Vivos Therapeutics, Inc. | -13.58 Million USD | -7.87% |
Acutus Medical, Inc. | -81.66 Million USD | 82.058% |
Talis Biomedical Corporation | -62 Million USD | 76.37% |
Spectral AI, Inc. | -20.85 Million USD | 29.74% |
Nano-X Imaging Ltd. | -60.77 Million USD | 75.892% |
CVRx, Inc. | -41.19 Million USD | 64.436% |
DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 2388.674% |
PetVivo Holdings, Inc. | -10.95 Million USD | -33.744% |
Bioventus Inc. | -156.23 Million USD | 90.622% |
Venus Concept Inc. | -37.25 Million USD | 60.666% |
TriSalus Life Sciences, Inc. | -59.03 Million USD | 75.182% |
LivaNova PLC | 17.54 Million USD | 183.506% |
908 Devices Inc. | -36.39 Million USD | 59.746% |
Alphatec Holdings, Inc. | -186.63 Million USD | 92.15% |
Nemaura Medical Inc. | -14.14 Million USD | -3.594% |
NeuroPace, Inc. | -32.95 Million USD | 55.541% |
LENSAR, Inc. | -14.38 Million USD | -1.87% |
Apyx Medical Corporation | -18.71 Million USD | 21.701% |
Cutera, Inc. | -162.83 Million USD | 91.002% |
STRATA Skin Sciences, Inc. | -10.83 Million USD | -35.291% |
BioSig Technologies, Inc. | -29.04 Million USD | 49.547% |
Anika Therapeutics, Inc. | -82.66 Million USD | 82.276% |
ClearPoint Neuro, Inc. | -22.08 Million USD | 33.668% |
Integra LifeSciences Holdings Corporation | 67.74 Million USD | 121.629% |
Axonics, Inc. | -6.08 Million USD | -140.67% |
Outset Medical, Inc. | -172.79 Million USD | 91.521% |
IRIDEX Corporation | -9.57 Million USD | -53.103% |
PROCEPT BioRobotics Corporation | -105.89 Million USD | 86.164% |
IRadimed Corporation | 17.19 Million USD | 185.222% |
Tivic Health Systems, Inc. | -8.24 Million USD | -77.729% |
INVO Bioscience, Inc. | -8.03 Million USD | -82.361% |
Telesis Bio, Inc. | -47.72 Million USD | 69.298% |
Viemed Healthcare, Inc. | 10.24 Million USD | 243.044% |
Varex Imaging Corporation | -47.7 Million USD | 69.283% |
Quipt Home Medical Corp. | -2.78 Million USD | -426.293% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -29.825% |
Pulmonx Corporation | -60.84 Million USD | 75.918% |
Dynatronics Corporation | -2.69 Million USD | -443.126% |
Modular Medical, Inc. | -17.47 Million USD | 16.131% |
ReShape Lifesciences Inc. | -11.38 Million USD | -28.673% |
Semler Scientific, Inc. | 20.58 Million USD | 171.185% |
InMode Ltd. | 197.91 Million USD | 107.403% |
Bruker Corporation | 427.2 Million USD | 103.43% |
Cytosorbents Corporation | -28.5 Million USD | 48.603% |
DexCom, Inc. | 541.5 Million USD | 102.706% |
Align Technology, Inc. | 445.05 Million USD | 103.292% |
Viveve Medical, Inc. | -22.02 Million USD | 33.482% |
ZimVie Inc. | -393.28 Million USD | 96.274% |
Movano Inc. | -29.28 Million USD | 49.964% |
Cytek Biosciences, Inc. | -12.14 Million USD | -20.612% |
Nexalin Technology, Inc. | -4.64 Million USD | -215.184% |
DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 2388.674% |
Tandem Diabetes Care, Inc. | -222.61 Million USD | 93.418% |
Profound Medical Corp. | -28.56 Million USD | 48.714% |
Insulet Corporation | 206.3 Million USD | 107.102% |
enVVeno Medical Corporation | -23.51 Million USD | 37.693% |
Surmodics, Inc. | -11.54 Million USD | -26.945% |
iCAD, Inc. | -4.84 Million USD | -202.29% |
Nuwellis, Inc. | -20.2 Million USD | 27.498% |
Biotricity, Inc. | -14.09 Million USD | -3.957% |
iRhythm Technologies, Inc. | -123.4 Million USD | 88.127% |
Aethlon Medical, Inc. | -12.2 Million USD | -20.018% |
InspireMD, Inc. | -19.91 Million USD | 26.431% |
PAVmed Inc. | -64.17 Million USD | 77.169% |
BIOLASE, Inc. | -20.63 Million USD | 28.984% |
Beyond Air, Inc. | -60.24 Million USD | 75.678% |
FONAR Corporation | 10.56 Million USD | 238.653% |
AxoGen, Inc. | -21.71 Million USD | 32.529% |
Vivani Medical, Inc. | -25.65 Million USD | 42.882% |
Tactile Systems Technology, Inc. | 28.51 Million USD | 151.383% |
Inari Medical, Inc. | -1.63 Million USD | -795.599% |
UFP Technologies, Inc. | 44.92 Million USD | 132.615% |
QT Imaging Holdings, Inc. | -5.13 Million USD | -185.484% |
Heart Test Laboratories, Inc. | -6.6 Million USD | -121.825% |
Tenon Medical, Inc. | -15.58 Million USD | 5.962% |
Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 5.018% |
Co-Diagnostics, Inc. | -35.33 Million USD | 58.532% |
AdaptHealth Corp. | -678.89 Million USD | 97.842% |
Sintx Technologies, Inc. | -8.25 Million USD | -77.406% |
NanoVibronix, Inc. | -3.71 Million USD | -294.826% |
Quanterix Corporation | -32.33 Million USD | 54.685% |
Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -29.825% |
Sensus Healthcare, Inc. | 485 Thousand USD | 3121.031% |
Pacific Biosciences of California, Inc. | -306.73 Million USD | 95.223% |
TransMedics Group, Inc. | -25.02 Million USD | 41.458% |
ReWalk Robotics Ltd. | -22.13 Million USD | 33.8% |
NeuroMetrix, Inc. | -6.52 Million USD | -124.397% |
Hyperfine, Inc. | -44.23 Million USD | 66.879% |
Establishment Labs Holdings Inc. | -78.5 Million USD | 81.336% |
Biomerica, Inc. | -5.97 Million USD | -145.099% |
Bone Biologics Corporation | -8.94 Million USD | -63.733% |
AVITA Medical, Inc. | -39.16 Million USD | 62.592% |
Bluejay Diagnostics, Inc. | -9.95 Million USD | -47.199% |
Silk Road Medical, Inc | -55.74 Million USD | 73.715% |